ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830,930 | -27.5% | 23,308 | -6.2% | 0.00% | -40.0% |
| Q2 2023 | $1,145,869 | +4674.5% | 24,840 | +6048.5% | 0.01% | – |
| Q2 2022 | $24,000 | +26.3% | 404 | +56.0% | 0.00% | – |
| Q1 2022 | $19,000 | -9.5% | 259 | +4.4% | 0.00% | – |
| Q4 2021 | $21,000 | +75.0% | 248 | +85.1% | 0.00% | – |
| Q3 2021 | $12,000 | -7.7% | 134 | -4.3% | 0.00% | – |
| Q2 2021 | $13,000 | -83.1% | 140 | -79.2% | 0.00% | -100.0% |
| Q1 2021 | $77,000 | +2.7% | 674 | +24.6% | 0.00% | 0.0% |
| Q4 2020 | $75,000 | – | 541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |